ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Funding Opportunities.

March 22, 2002

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012